Shared on 31 Oct 25
Fair value Decreased 2.49%Analysts have revised their price target for Sasol downward from R134.11 to R130.78, citing slightly increased discount rates even though revenue growth and profit margin forecasts have improved. What's in the News Sasol International Chemicals has launched and commercialized LIVINEX IO 7, a bio-circular, palm and deforestation-free surfactant made from insect oils (Key Developments).
Shared on 28 Aug 25
Fair value Increased 8.54%Sasol’s valuation outlook is essentially unchanged, as both the discount rate and future P/E saw only marginal adjustments, leaving the consensus analyst price target steady at ZAR123.56. What's in the News Sasol Limited expects EPS for the fiscal year ended June 2025 to increase by over 20% versus the prior year's loss per share of ZAR 69.94, which was heavily affected by negative remeasurement items of ZAR 88.13 per share (Key Developments).
Shared on 23 Apr 25
Fair value Decreased 1.04%AnalystConsensusTarget has decreased revenue growth from 2.3% to 1.9%.
Shared on 17 Apr 25
Fair value Decreased 1.78%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 09 Apr 25
Fair value Decreased 1.91%AnalystConsensusTarget has decreased revenue growth from 2.7% to 2.5%.
Shared on 02 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 26 Mar 25
Fair value Decreased 1.96%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 19 Mar 25
Fair value Decreased 5.40%AnalystConsensusTarget has decreased revenue growth from 3.2% to 2.8%.
Shared on 12 Mar 25
Fair value Decreased 0.55%AnalystConsensusTarget has increased revenue growth from 2.0% to 3.2%, increased profit margin from 9.9% to 18.1% and decreased future PE multiple from 6.6x to 3.6x.